Phytochemical Constituents, Antioxidant Activity, and Toxicity Assessment of the Seed of Spondias mombin L. (Anacardiaceae). 2020

Oyindamola Olajumoke Abiodun, and Mesoma Esther Nnoruka, and Rasidat Olufunke Tijani
University of Ibadan College of Medicine, Department of Pharmacology and Therapeutics, Ibadan, Nigeria.

OBJECTIVE Increased generation of free radicals exceeding the antioxidant capacity of the host is deleterious. Thus new, potent, and safe antioxidants will be a valuable addition to the limited antioxidant arsenals available. Therefore, the antioxidant activity, cytotoxicity potential, and phytochemical constituents of the methanol extract of Spondias mombin seed (MESSM) were investigated. METHODS 2,2-diphenyl-1-picrylhydrazyl (DPPH), nitric oxide (NO), and hydrogen peroxide (H2O2) were the antioxidant assays used. The cytotoxicity of MESSM was evaluated against a rhabdomyosarcoma (RD) cell line in a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide based assay. The phytochemical constituents of MESSM were identified using gas chromatography-mass spectrometry. RESULTS MESSM produced better antioxidant activity in the DPPH (IC50=58.64±1.49 μg/mL) and H2O2 (IC50=44.03±5.57 μg/mL) assays than in the NO (IC50=494.55±12.68 μg/mL, p<0.0001) assay. Moreover, MESSM was nontoxic (CC50=139.6±0.54 μg/mL) in comparison to cyclophosphamide (CC50=0.97±0.03 μg/mL) against the RD cell line. The major compounds in MESSM were dodecanoic acid (22.48%), tetradecanoic acid (17.95%), n-hexadecanoic acid (15.35%), capsaicin (12.11%), and dihydrocapsaicin (5.23%). CONCLUSIONS The seed extract of Spondias mombin contains nontoxic antioxidant compounds that could be explored in the pharmaceutical and cosmetics industries for the development of antioxidant agents.

UI MeSH Term Description Entries

Related Publications

Oyindamola Olajumoke Abiodun, and Mesoma Esther Nnoruka, and Rasidat Olufunke Tijani
January 2017, Biologics : targets & therapy,
Oyindamola Olajumoke Abiodun, and Mesoma Esther Nnoruka, and Rasidat Olufunke Tijani
March 2022, 3 Biotech,
Oyindamola Olajumoke Abiodun, and Mesoma Esther Nnoruka, and Rasidat Olufunke Tijani
January 2006, Journal of ethnopharmacology,
Oyindamola Olajumoke Abiodun, and Mesoma Esther Nnoruka, and Rasidat Olufunke Tijani
September 2008, African health sciences,
Oyindamola Olajumoke Abiodun, and Mesoma Esther Nnoruka, and Rasidat Olufunke Tijani
November 2011, Genetics and molecular research : GMR,
Oyindamola Olajumoke Abiodun, and Mesoma Esther Nnoruka, and Rasidat Olufunke Tijani
November 2017, Pakistan journal of pharmaceutical sciences,
Oyindamola Olajumoke Abiodun, and Mesoma Esther Nnoruka, and Rasidat Olufunke Tijani
January 2020, Cardiovascular & hematological disorders drug targets,
Oyindamola Olajumoke Abiodun, and Mesoma Esther Nnoruka, and Rasidat Olufunke Tijani
January 2017, Oxidative medicine and cellular longevity,
Oyindamola Olajumoke Abiodun, and Mesoma Esther Nnoruka, and Rasidat Olufunke Tijani
June 2012, Veterinary parasitology,
Oyindamola Olajumoke Abiodun, and Mesoma Esther Nnoruka, and Rasidat Olufunke Tijani
February 2021, Journal of food science and technology,
Copied contents to your clipboard!